Alkylamido compounds and uses thereof
Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.
1. A method of treating psoriasis in a subject in need thereof, comprising administering a pharmaceutically effective amount of the compound N-acetyl-(R)-3-(4-aminophenyl)-2-methoxypropionic acid or a pharmaceutically acceptable salt or N-oxide thereof.
2. The method of claim 1 , wherein the psoriasis is at least one of: cutaneous, mucosal or ungual psoriasis.
3. The method of claim 1 , wherein the compound is administered orally or topically.
4. A method of treating psoriasis comprising administering a pharmaceutically effective amount of a pharmaceutical composition, wherein the pharmaceutical composition comprises:
N-acetyl-(R)-3-(4-aminophenyl)-2-methoxypropionic acid or a pharmaceutically acceptable salt or N-oxide thereof, and
a pharmaceutically acceptable carrier.
5. A method of treating psoriasis in a subject in need thereof, comprising administering a pharmaceutically effective amount of the compound N-acetyl-(S)-3-(4-aminophenyl)-2-methoxypropionic acid or a pharmaceutically acceptable salt or N-oxide thereof.
6. The method of claim 5 , wherein the psoriasis is at least one of: cutaneous, mucosal or ungual psoriasis.
7. The method of claim 5 , wherein the compound is administered orally or topically.
8. A method of treating psoriasis comprising administering a pharmaceutically effective amount of a pharmaceutical composition, wherein the pharmaceutical composition comprises:
N-acetyl-(S)-3-(4-aminophenyl)-2-methoxypropionic acid or a pharmaceutically acceptable salt or N-oxide thereof, and
a pharmaceutically acceptable carrier.